Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease

NCT07625774 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

3690

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: HRS-7535
DRUG: Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.